Our Q2/2025 summary based on our clients' results!

After the summer lull, stock markets are gearing up for an active autumn. Despite recent market gains, investing in stocks remains worthwhile, driven by long-term growth opportunities. Digitalization, artificial intelligence, quantum computing, and the green transition are reshaping industries, boosting productivity, and opening exciting prospects. Market fluctuations provide investors with excellent buying opportunities—promising decades ahead for those navigating the stock market.

Consensus estimates are now available for Deutsche Telekom, Commerzbank, Aixtron, and Sandoz!

Our Q1/2025 summary based on our clients' results!

Syndax Pharmaceuticals, a commercial-stage oncology innovator with two first-in-class products, has made its consensus estimates accessible on VARA Pro.

Michael Vara’s Column: How to Build a Stock Portfolio and Avoid Social Media Fakes

Michael Vara’s Column: Ukraine, Trump, and Market Moves: What 2025 Might Bring

VARA News - Signals From VARA Pro Q3/2024

Michael Vara’s Column: Stock Investing: One of the Best Life Coaches

Michael Vara’s Column: Should Cities Invest in Stocks? Kurikka thinks so

VARA News Anora Group's Consensus Now Available On VARA Pro

This review outlines how our clients performed during the second quarter of 2024.

Vara Research has rebranded to VARA, ushering in a new era of innovation and excellence.